CD47 and lymphoma: It has been shown that the use of anti CD47 antibodies lead to increased phagocytic activity of SIRP-alpha (SIRP-α) bearing macrophages (97), thereby indicating that overexpression of CD47 and SIRP-alpha is a lymphoma cell mechanism to evade macrophage-mediated destruction.